Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Xiao-Cui Hong"'
Autor:
Xiao-Cui Hong, Qi-Lian Liang, Man Chen, Hai-Xia Yang, Jie Huang, Si-Lin Yi, Zhen-Wei Wang, Hai-Yan Liang, Ding-Yue Zhang, Zeng-Yi Huang
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
ObjectiveTo evaluate the clinical correlation of epithelial-mesenchymal transition (EMT) with PRL-3 and MMP9 expression in the circulating tumor cells (CTCs) of patients with colorectal cancer (CRC).Materials and MethodsBetween January 2016 and Decem
Externí odkaz:
https://doaj.org/article/88b94712ce9e450ba126000b0f4de571
Publikováno v:
Jichu yixue yu linchuang, Vol 41, Iss 4, Pp 568-572 (2021)
Objective To study the clinical outcome of short segment percutaneous pedicle screw(PPS) combined with unilateral percutaneous vertebroplasty(PVP) for Kümmell disease stage Ⅲ without neurological symptoms. Methods Retrospective analysis of 11 pati
Externí odkaz:
https://doaj.org/article/f78ad8febeb044f985da68235c613437
Autor:
Shao-ang Cheng, Xin Huang, Liang Jiang, Qi-Lian Liang, Xiao-Cui Hong, Hai-Xia Yang, Ke-Hui Hu, Xing-Bo Luo, Hui-Jie Zhang
Publikováno v:
Open medicine (Warsaw, Poland). 17(1)
The aim of this study is to reveal the potential value of dynamin3 (DNM3) in colorectal cancer (CRC) evaluation of clinical diagnosis and prognosis. A total of 100 tissue samples were collected from 50 patients with stages I–IV, CRC tissues (n = 50
Publikováno v:
Cancer Management and Research. 11:4773-4780
Background: Cervical cancer is strongly associated with persistent human papillomavirus (HPV) infections. The ThinPrep cytologic test (TCT), HPV DNA detection, and E6/E7 mRNA testing are widely used to screen for cervical abnormalities. Purpose: This
Autor:
Hui-Jie Zhang, Gao-Le Yuan, Shao-Ang Cheng, Xiao-Xia Peng, Xing-Bo Luo, Qi-Lian Liang, Xiao-Cui Hong
Publikováno v:
World Journal of Clinical Cases
Ectopic thoracic kidneys are the rarest form of renal ectopia. Moreover, congenital abnormality of a primary anterior inferior vena cava (IVC) located behind the anterior abdominal wall is extremely rare. To date, only one such case has been reported
Autor:
Xiao-Cui Hong, Liang Jiang, Xiao-Xia Peng, Li-Zhong Liang, Qi-Lian Liang, Xing-Bo Luo, Shao-Ang Cheng, Gao-Le Yuan, Hui-Jie Zhang, Zhen-Yi Huang
Publikováno v:
Cancer Management and Research
Background: To investigate the epidemiologic features of breast cancer laterality and molecular subtypes in Southern China, we retrospectively analyzed the clinical data of patients with a definite diagnosis of breast cancer in 2013-2017. Methods: Da
Autor:
Shao-ang Cheng, Xin Huang, Liang Jiang, Qi-Lian Liang, Xiao-Cui Hong, Hai-Xia Yang, Ke-Hui Hu, Xing-Bo Luo, Hui-Jie Zhang
Publikováno v:
Open Medicine; Jan2022, Vol. 17 Issue 1, p221-226, 6p, 1 Diagram, 4 Charts
Autor:
Xiao-Cui Hong, Qi-Lian Liang, Xing-Bo Luo, Ke-Hui Hu, Hai-Xia Yang, Wen-ting Ou, Hui-Jie Zhang
Background The total effective rate of first-line chemotherapy based on fluorouracils and platinum for advanced gastric cancer is about 31%-64%, but most of Patients will develop worse after 3-8 months, while second-line chemotherapy is seems ineffic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bbbc4b3ff259e7818728cf43b4f13c86
https://doi.org/10.21203/rs.2.17152/v1
https://doi.org/10.21203/rs.2.17152/v1
Autor:
Xiao-Cui Hong, Ke-Hui Hu, Hai-Xia Yang, Xing-Bo Luo, Hui-Jie Zhang, Wen-Ting Ou, Qi-Lian Liang
Publikováno v:
Medicine
Supplemental Digital Content is available in the text
Introduction: S-1, a new oral fluorouracil chemotherapeutical drug, has been increasingly used in clinical maintenance after first-line chemotherapy for stage III or IV gastric carcinoma (GC)
Introduction: S-1, a new oral fluorouracil chemotherapeutical drug, has been increasingly used in clinical maintenance after first-line chemotherapy for stage III or IV gastric carcinoma (GC)
Autor:
Zhang Q; Department of Biochemistry and Molecular Biology, Wuhan University School of Basic Medical Sciences, Wuhan, China.; Wuhan Hamilton Biotechnology Co, Wuhan, China., Xiang E; Department of Biochemistry and Molecular Biology, Wuhan University School of Basic Medical Sciences, Wuhan, China.; Wuhan Hamilton Biotechnology Co, Wuhan, China., Rao W; Wuhan Hamilton Biotechnology Co, Wuhan, China., Zhang YQ; Department of Biochemistry and Molecular Biology, Wuhan University School of Basic Medical Sciences, Wuhan, China., Xiao CH; Wuhan Hamilton Biotechnology Co, Wuhan, China., Li CY; Department of Physiology, Wuhan University School of Basic Medical Sciences, Wuhan, China., Han B; Wuhan Hamilton Biotechnology Co, Wuhan, China., Wu D; Department of Biochemistry and Molecular Biology, Wuhan University School of Basic Medical Sciences, Wuhan, China.; Wuhan Hamilton Biotechnology Co, Wuhan, China.
Publikováno v:
Bone & joint research [Bone Joint Res] 2021 Mar; Vol. 10 (3), pp. 226-236.